메뉴 건너뛰기




Volumn 141, Issue 5, 2011, Pages 1238-1245

Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLACENTAL GROWTH FACTOR; RINGER SOLUTION;

EID: 79954578354     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.10.054     Document Type: Article
Times cited : (15)

References (24)
  • 3
    • 0041915801 scopus 로고    scopus 로고
    • Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers
    • K. Tambara, Y. Sakakibara, G. Sakaguchi, F. Lu, G.U. Premaratne, and X. Lin Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers Circulation 2003 108 Suppl. 1:II259-63
    • (2003) Circulation , pp. 108
    • Tambara, K.1    Sakakibara, Y.2    Sakaguchi, G.3    Lu, F.4    Premaratne, G.U.5    Lin, X.6
  • 4
    • 33746930399 scopus 로고    scopus 로고
    • Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase i cohort of patients
    • A.A. Hagge, J.P. Marolleau, J.T. Vilquin, A. Alhritiére, S. Peyrard, and D. Duboc Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients Circulation 114 1 Suppl 2006 I108 I113
    • (2006) Circulation , vol.114 , Issue.1 SUPPL.
    • Hagge, A.A.1    Marolleau, J.P.2    Vilquin, J.T.3    Alhritiére, A.4    Peyrard, S.5    Duboc, D.6
  • 6
    • 48749124007 scopus 로고    scopus 로고
    • Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation
    • S. Aharinejad, D. Abraham, P. Paulus, K. Zins, M. Hofmann, and W. Michlits Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation Cardiovasc Res 79 2008 395 404
    • (2008) Cardiovasc Res , vol.79 , pp. 395-404
    • Aharinejad, S.1    Abraham, D.2    Paulus, P.3    Zins, K.4    Hofmann, M.5    Michlits, W.6
  • 8
    • 34748917848 scopus 로고    scopus 로고
    • Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair
    • L. Ye, H.K.h Haider, R. Tan, W. Toh, P.K. Law, and W. Tan Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair Circulation 116 11 Suppl 2007 I113 I120
    • (2007) Circulation , vol.116 , Issue.11 SUPPL.
    • Ye, L.1    Haider, H.K.H.2    Tan, R.3    Toh, W.4    Law, P.K.5    Tan, W.6
  • 9
    • 12344274486 scopus 로고    scopus 로고
    • The biology of vascular endothelial growth factors
    • DOI 10.1016/j.cardiores.2004.12.002, PII S0008636304005498
    • T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res 65 2005 550 563 (Pubitemid 40138976)
    • (2005) Cardiovascular Research , vol.65 , Issue.3 , pp. 550-563
    • Tammela, T.1    Enholm, B.2    Alitalo, K.3    Paavonen, K.4
  • 11
    • 0038692867 scopus 로고    scopus 로고
    • 164/165 and PlGF: Roles in angiogenesis and arteriogenesis
    • DOI 10.1016/S1050-1738(03)00056-2, PII S1050173803000562
    • J.A. Nagy, A.M. Dvorak, and H.F. Dvorak VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis Trends Cardiovasc Med 13 2003 169 175 (Pubitemid 36802019)
    • (2003) Trends in Cardiovascular Medicine , vol.13 , Issue.5 , pp. 169-175
    • Nagy, J.A.1    Dvorak, A.M.2    Dvorak, H.F.3
  • 12
    • 0036344495 scopus 로고    scopus 로고
    • Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
    • A. Luttun, M. Tjwa, L. Moons, Y. Wu, A. Angelillo-Scherrer, and F. Liao Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Nat Med 8 2002 831 840
    • (2002) Nat Med , vol.8 , pp. 831-840
    • Luttun, A.1    Tjwa, M.2    Moons, L.3    Wu, Y.4    Angelillo-Scherrer, A.5    Liao, F.6
  • 13
    • 0028956308 scopus 로고
    • Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer
    • J. DiSalvo, M.L. Bayne, G. Conn, P.W. Kwok, P.G. Trivedi, and D.D. Soderman Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer J Biol Chem 270 1995 7717 7723
    • (1995) J Biol Chem , vol.270 , pp. 7717-7723
    • Disalvo, J.1    Bayne, M.L.2    Conn, G.3    Kwok, P.W.4    Trivedi, P.G.5    Soderman, D.D.6
  • 14
    • 33646026421 scopus 로고    scopus 로고
    • Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction
    • H. Iwama, S. Uemura, N. Naya, K. Imagawa, Y. Takemoto, and O. Asai Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction J Am Coll Cardiol 47 2006 1559 1567
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1559-1567
    • Iwama, H.1    Uemura, S.2    Naya, N.3    Imagawa, K.4    Takemoto, Y.5    Asai, O.6
  • 15
    • 0036962410 scopus 로고    scopus 로고
    • Placental growth factor (PIGF) and its receptor Flt-1 (VEGFR-1): Novel therapeutic targets for angiogenic disorders
    • A. Luttun, M. Tjwa, and P. Carmeliet Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders Ann N Y Acad Sci 979 2002 80 93 (Pubitemid 36121141)
    • (2002) Annals of the New York Academy of Sciences , vol.979 , pp. 80-93
    • Luttun, A.1    Tjwa, M.2    Carmeliet, P.3
  • 16
    • 53149097323 scopus 로고    scopus 로고
    • Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance
    • C. Roncal, I. Buysschaert, E. Chorianopoulos, M. Georgiadou, O. Meilhac, and M. Demol Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance J Pathol 216 2008 236 244
    • (2008) J Pathol , vol.216 , pp. 236-244
    • Roncal, C.1    Buysschaert, I.2    Chorianopoulos, E.3    Georgiadou, M.4    Meilhac, O.5    Demol, M.6
  • 18
    • 31344477231 scopus 로고    scopus 로고
    • Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window
    • DOI 10.1016/j.cardiores.2005.10.002, PII S0008636305004736
    • D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window Cardiovasc Res 69 2006 604 613 (Pubitemid 43139724)
    • (2006) Cardiovascular Research , vol.69 , Issue.3 , pp. 604-613
    • Vanhoutte, D.1    Schellings, M.2    Pinto, Y.3    Heymans, S.4
  • 19
    • 32444441006 scopus 로고    scopus 로고
    • Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction
    • DOI 10.1007/s10557-005-5201-6
    • A. Tessone, M.S. Feinberg, I.M. Barbash, R. Reich, R. Holbova, and M. Richmann Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction Cardiovasc Drugs Ther 19 2005 383 390 (Pubitemid 43228149)
    • (2005) Cardiovascular Drugs and Therapy , vol.19 , Issue.6 , pp. 383-390
    • Tessone, A.1    Feinberg, M.S.2    Barbash, I.M.3    Reich, R.4    Holbova, R.5    Richmann, M.6    Mardor, Y.7    Leor, J.8
  • 23
    • 1042268055 scopus 로고    scopus 로고
    • Matrix Metalloproteinase-9 Is Required for Adequate Angiogenic Revascularization of Ischemic Tissues: Potential Role in Capillary Branching
    • DOI 10.1161/01.RES.0000111527.42357.62
    • C. Johnson, H.J. Sung, S.M. Lessner, M.E. Fini, and Z.S. Galis Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching Circ Res 94 2004 262 268 (Pubitemid 38197460)
    • (2004) Circulation Research , vol.94 , Issue.2 , pp. 262-268
    • Johnson, C.1    Sung, H.-J.2    Lessner, S.M.3    Fini, M.E.4    Galis, Z.S.5
  • 24
    • 24044458235 scopus 로고    scopus 로고
    • Combination of tumor necrosis factor-α ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice
    • DOI 10.1161/01.RES.0000178789.16929.cf
    • Z. Kassiri, G.Y. Oudit, O. Sanchez, F. Dawood, F.F. Mohammed, and R.K. Nuttall Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice Circ Res 97 2005 380 390 (Pubitemid 41216143)
    • (2005) Circulation Research , vol.97 , Issue.4 , pp. 380-390
    • Kassiri, Z.1    Oudit, G.Y.2    Sanchez, O.3    Dawood, F.4    Mohammed, F.F.5    Nuttall, R.K.6    Edwards, D.R.7    Liu, P.P.8    Backx, P.H.9    Khokha, R.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.